PD-1 is currently a well-studied immune checkpoint (ICP) and its ligand, PD-L1, is overexpressed in LC, whereas metastasis of cancer cells occurs by promoting evasion of immune surveillance (46, 139). This evidence concerns the gene CD274 and laryngotracheoesophageal cleft.